December 7, 2016 — Abbott has filed a complaint to terminate its proposed acquisition of Alere based on the substantial ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
November 15, 2016 — Atrial fibrillation patients who use warfarin to lower risk of stroke are at higher risk of ...
November 14, 2016 — Atrial fibrillation patients with a prior history of stroke who undergo catheter ablation lower ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
November 10, 2016 — Siemens Healthineers announced U.S. Food and Drug Administration (FDA) 510(k) clearance for a hand ...
November 7, 2016 – Results from the U.S. real-world, post-FDA approval experience of the Watchman device found high ...
October 27, 2016 — Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
October 25, 2016 — A recent study from University of Alabama at Birmingham (UAB) researchers published in PLOS ONE compa ...
October 20, 2016 — SentreHeart Inc. announced in late September the closing of a $35 million Series D round of financing ...
October 17, 2016 — Medtronic plc last week unveiled new health economic analysis data from the FIRE AND ICE trial that ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
October 13, 2016 — SentreHeart Inc. announced this week it has treated the first patients using the Eclipse Surgical ...
New cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF) are rapidly evolving with the ...
September 27, 2016 — In August, the European Heart Rhythm Association (EHRA) and EP Europace journal announced the ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
September 1, 2016 — First outcome results from the GLORIA-AF Registry show that treatment with Pradaxa (dabigatran ...
August 30, 2016 — Medtronic plc announced results from the Cardiac Resynchronization Therapy Efficacy Enhancement (CRTee ...
August 29, 2016 — Investment research firm Muddy Waters Capital released a report Aug. 25 saying it believes St. Jude ...